CD44, a transmembrane glycoprotein that belongs to a family of cell adhesion molecules, is involved with the progression and metastasis of multiple types of cancer [3]–[6] and has been associated with a poor prognosis in CRC patients [3]. Here, CD44 is linked to cancer.